Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Veterinary Dermatology|January 25, 2018
In vitro antimicrobial activity of narasin against common clinical isolates associated with canine otitis externaWei Yee Chan, Elizabeth E Hickey, Manouchehr Khazandi, et al.
Veterinary Dermatology|November 12, 2019
In vitro antimicrobial activity of narasin and monensin in combination with adjuvants against pathogens associated with canine otitis externaWei Yee Chan, Elizabeth E Hickey, Manouchehr Khazandi, et al.
BJGP Open|December 9, 2020
Evaluating the delay prior to primary care presentation in patients with lung cancer: a cohort studyJalpa Kotecha, Allan Clark, Matthew Burton, et al.
Age and Ageing|July 21, 2014
Effect of medications with anti-cholinergic properties on cognitive function, delirium, physical function and mortality: a systematic reviewChris Fox, Toby Smith, Ian Maidment, et al.
Frontiers in Microbiology|May 21, 2019
In vitro Antimicrobial Activity of Robenidine, Ethylenediaminetetraacetic Acid and Polymyxin B Nonapeptide Against Important Human and Veterinary PathogensManouchehr Khazandi, Hongfei Pi, Wei Yee Chan, et al.
The EMBO Journal|June 17, 2024
Multi-signal regulation of the GSK-3β homolog Rim11 controls meiosis entry in budding yeastJohanna Kociemba, Andreas Christ Sølvsten Jørgensen, Nika Tadić, et al.
Plos One|July 17, 2018
Bioluminescent murine models of bacterial sepsis and scald wound infections for antimicrobial efficacy testingAbiodun D Ogunniyi, Zlatko Kopecki, Elizabeth E Hickey, et al.
Age and Ageing|July 1, 2020
Anticholinergic drugs and incident dementia, mild cognitive impairment and cognitive decline: a meta-analysisNina T Pieper, Carlota M Grossi, Wei-Yee Chan, et al.
British Journal of Haematology|July 18, 2020
Clinical outcomes and risk factors for severe COVID-19 in patients with haematological disorders receiving chemo- or immunotherapyThomas A Fox, Ethan Troy-Barnes, Amy A Kirkwood, et al.
Blood|August 30, 2023
Molecular MRD is strongly prognostic in patients with NPM1-mutated AML receiving venetoclax-based nonintensive therapyJad Othman, Ing S Tiong, Jenny O'Nions, et al.
Pageof 2